Calidi Biotherapeutics Inc (CLDI)
0.236
-0.01
(-4.88%)
USD |
NYAM |
May 21, 16:00
0.235
0.00 (0.00%)
After-Hours: 20:00
Calidi Biotherapeutics Free Cash Flow (Quarterly): -3.836M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -3.836M |
December 31, 2023 | -5.256M |
September 30, 2023 | -10.34M |
Date | Value |
---|---|
March 31, 2023 | -3.244M |
December 31, 2022 | |
September 30, 2022 | -9.605M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-10.34M
Minimum
Sep 2023
-3.244M
Maximum
Mar 2023
-6.457M
Average
-5.256M
Median
Dec 2023
Free Cash Flow (Quarterly) Benchmarks
Minerva Neurosciences Inc | -6.094M |
Viking Therapeutics Inc | -6.134M |
CytomX Therapeutics Inc | -26.16M |
Genprex Inc | -5.315M |
Janux Therapeutics Inc | -15.03M |